Illumina Inc.’s stock
ILMN,
fell 14% Friday to put it on track for its lowest close in 10 years, after the company after the maker of DNA-sequencing technology cut its full-year sales and profit guidance after missing revenue estimates for the third quarter. The stock was last quoted at $91.16. The last time it traded below $92 was in 2013. The stock has fallen for four of the past five days and is down three straight days, according to Dow Jones Market Data. It’s down 18.8% in that period to mark the worst three-day stretch since it fell 24.7% in the three days through May 10, 2022. The stock has fallen 54% in the year to date, while the S&P 500
SPX,
has gained 14%.
